OMCL Stock Analysis: Buy, Sell, or Hold?
OMCL - Omnicell Inc
$35.58
0.08 (0.23%)
▲
5d:
-4.61%
30d:
-10.74%
90d:
-18.69%
HOLD
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Jul 30, 2026
0d
Get Alerted When OMCL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: OMCL shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: OMCL shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$37.71
Based on -2.0% avg growth
INTRINSIC VALUE TODAY
$23.41
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: OMCL is currently trading at $35.58, which is considered oversold relative to its 30-day fair value range of $35.71 to $43.15. From a valuation perspective, the stock is trading at a discount (Forward PE: 17.0) compared to its historical average (20.0). Remarkably, the market is currently pricing in an annual earnings decline of 5.2% over the next few years. This pessimistic expectation contrasts with the company's recent 333.3% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, OMCL is showing sideways momentum. The price is currently testing key support at $35.17. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: OMCL scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $57.86 (+62.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, OMCL is showing sideways momentum. The price is currently testing key support at $35.17. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: OMCL scores 75/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $57.86 (+62.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$35.71 -
$43.15
Company Quality Score
61/100
(BUY)
Options IV Signal
50th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
86.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 50th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 62.6% below Wall St target ($57.86)
- CAUTION: Bottoming setup, but lagging the sector by 13% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$35.71 -
$43.15
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$2.51
(7.1%)
Support & Resistance Levels
Support Level
$35.17
Resistance Level
$37.96
Current Trend
Sideways
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
17.02
Wall Street Target
$57.86
(+62.6%)
Revenue Growth (YoY)
7.5%
Earnings Growth (YoY)
333.3%
Profit Margin
3.1%
Valuation Discount vs History
-5.2% cheaper
PE vs Historical
17.0 vs 20.0
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-5.2%
(market-implied from PE analysis)
1-Year Target
$33.73
(-5%)
2-Year Target
$31.98
(-10%)
3-Year Target
$30.31
(-15%)
3-Yr Target (if PE normalizes)
(PE: 17→20)
$35.61
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: -7.9%)
$32.79
(+-8%)
Base:
(SPY PE: 17.0, Growth: -7.9%)
$27.81
(-22%)
Bear:
(PE: 14.5, Growth: -7.9%)
$23.64
(-34%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (42x PE), but valuation improves significantly next year (17x PE) as earnings recover.
Trailing PE: 42.26 | Current EPS (TTM): $0.84
Bull Case
$78.10
(+120%)
Analyst growth 100.0%, PE expands to 46.5
Base Case
$71.00
(+100%)
Market implied 100.0%, PE stable at 42.3
Bear Case
$24.14
(-32%)
Severe decline -20.0%, PE contracts to 35.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 17.0 to 20.0
Stabilization Target:
$41.80
(+17.5%)
PE Expansion Potential:
+17.5%
Share & Embed Analysis
Last updated: August 22, 2026 5:27 PM ET
Data refreshes hourly during market hours. Next update: 6:27 PM
Data refreshes hourly during market hours. Next update: 6:27 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OMCL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Corey J Manley
SELL
7405 shares
2026-03-16
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 50 HOLD |
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$244 | 33 SELL |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 51 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 37 SELL |
|
BTSG
BrightSpring Health Serv… |
STRONG BUY
12 analysts |
$79 | 63 BUY |
